Investor Relations · PatentInvest
PatentInvest LLC.
The intellectual property holding company for the group. A Wyoming limited liability company formed in September 2026 and held directly by the founder. It is the holding company formed to own the group’s patent applications; the founder, who filed all 33 as sole inventor, is assigning them to it. Each operating company will take an exclusive licence in its field from PatentInvest.
The portfolio
Counts and fields
The filings fall into the four technology areas described on the portfolio page: AI reliability and verification; agentic AI orchestration; digital health and clinical AI; and behavioural and financial incentive systems. The inventor on every filing is the founder. The 236 catalogued inventions include the 33 that are filed; the rest are drafted or recorded and are reviewed for filing in order of value.
Two product families will be held in PatentInvest as licensable assets rather than inside an operating company: Synapta, an AI-assisted therapy platform, and CommitVest, a commitment-contract system. They will be available for licence. Status of both: In beta testing.
“Patent pending” means that a U.S. provisional or non-provisional application has been filed. No patent has been granted, and there is no assurance that any will be.
Licensing
How the licences work
Each operating company will take an exclusive licence in its field from PatentInvest. Trouvera Health will take digital health. AttestAlly will take verification. IndieStarlight will take the creator marketplace. Each licence will be exclusive within its field and will cover improvements and later filings in the same family. It is being drafted to survive a change of control of the operating company. Each is planned to carry a purchase option on defined terms.
Fields outside those three will stay with PatentInvest. They will be available for licence to third parties, and enquiries are welcome through the portfolio page.
Counsel
The counsel programme
The applications were drafted and filed by the founder. PatentInvest is engaging patent counsel to review each filing, correct the record where needed, and advise on which provisional applications to convert as they come due. Counsel may take a small interest in PatentInvest for that work. The first conversion decisions fall in December 2026, and the largest group falls between January and March 2027.
Public good
Open inventions
Some inventions we will not commercialise but that could help people. Those are released on the Open Inventions page as dated, hashed public-domain write-ups with a pledge not to assert patents against the use described. PatentInvest is also planning a public pledge covering the inventions that the Trouvera.org guides programme relies on, so that the programme does not depend on the company.
Plan
The next eighteen months
- Complete the assignment of the 33 applications from the founder to PatentInvest, with counsel, and record it at the USPTO.
- Sign the exclusive field licences with Trouvera Health, AttestAlly and IndieStarlight as each company is formed.
- Decide each provisional application’s conversion as it comes due, starting in December 2026.
- Decide the international filing on the non-provisional application in early 2027; it is expected to publish in February 2027.
- Continue filing new provisional applications from the catalogue, and release the first open inventions.
This page is for informational purposes only and does not constitute an offer to sell, or the solicitation of an offer to buy, any security, nor investment, legal, financial or tax advice. Any offer would be made only to eligible investors through definitive offering documents. Forward-looking statements are subject to risk and uncertainty and are not guarantees of future performance.